Wall Street analysts forecast that Thermo Fisher Scientific (TMO) will report quarterly earnings of $5.64 per share in its upcoming release, pointing to a year-over-year increase of 4.4%. It is anticipated that revenues will amount to $10.74 billion, exhibiting a decline of 6.2% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.1% to its current level. This demonstrates the covering analysts' collective reassessment of their in ...

Thermo Fisher Scientific (TMO) closed at $553.39 in the latest trading session, marking a +0.3% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.22%. On the other hand, the Dow registered a gain of 0.36%, and the technology-centric Nasdaq increased by 0.32%.The maker of scientific instrument and laboratory supplies's stock has climbed by 4.29% in the past month, exceeding the Medical sector's gain of 2.3% and the S&P 500's gain of 1.61%.Analysts and investors alike wil ...

Thermo Fisher Scientific Inc. (TMO) is likely to gain in the coming quarters, backed by a slew of impressive product introductions across the portfolio. Promising developments within the company’s growth strategy, consisting of developing high-impact, innovative new products, leveraging scale and high growth in emerging markets and delivering a unique value proposition to customers, are encouraging. Stable solvency is an added upside.However, macroeconomic headwinds and competitive pressures may pose challe ...

Thermo Fisher Scientific Inc. (TMO) is slated to release fourth-quarter 2023 results on Jan 31, 2024, before market open.Thermo Fisher’s earnings of $5.69 per share in the last reported quarter topped the Zacks Consensus Estimate by 1.9%. Its earnings surpassed estimates in three of the trailing four quarters, the average surprise being 0.62%.Let's discuss the factors that are likely to be reflected in the upcoming results.Factors at PlayLike the last quarter, Thermo Fisher’s Analytical Instruments segment ...

The most recent trading session ended with Thermo Fisher Scientific (TMO) standing at $544.32, reflecting a -0.31% shift from the previouse trading day's closing. This move lagged the S&P 500's daily gain of 0.08%. Elsewhere, the Dow saw a downswing of 0.31%, while the tech-heavy Nasdaq appreciated by 0.02%.Shares of the maker of scientific instrument and laboratory supplies witnessed a gain of 4.69% over the previous month, trailing the performance of the Medical sector with its gain of 6.57% and outperfor ...

Marc N. Casper Chairman, President and Chief Executive Officer Please note that the attached presentations contain financial projections and other forward-looking statements that are specific to the date of the presentation and should not be considered current after such date. • Incredibly well-positioned industry leader serving very attractive end markets • We have an outstanding track record of financial performance and an excellent long-term outlook abservices 4 Industry-leading scale Unmatched depth of ...

Thermo Fisher Scientific, Inc. (NYSE:TMO) 42nd Annual J.P. Morgan Healthcare Conference January 9, 2023 11:15 AM ET Company Participants Marc Casper – Chief Executive Officer Conference Call Participants Rachel Vatnsdal – J.P. Morgan Rachel Vatnsdal Perfect. Good morning everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team here at J.P. Morgan. I'm joined on stage by Marc Casper, CEO of Thermo Fisher. So as we typically do, this is going to be a 40 minute session. First of it, h ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the “Buyer”), has extended the expiration time of the offering period of its previously announced tender offer (the “Offer”) to acquire all of the outstanding common shares (“Shares”) and all of the outstanding American Depositary Shares, each representing one Share (“ADSs” and, together with the Shares, the “Offe ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 11:15 a.m. (EST). You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in servi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number 1-8002 THERMO FISHER SCIENTIFIC INC. (Exact name of Registrant as specified in its charter) Delaware 04-2209186 (State of incorporation) (I.R.S. Employer Identification No.) ...